Relative Dose Intensity and Pathologic Response Rates in Patients With Breast Cancer and With and Without HIV Who Received Neoadjuvant Chemotherapy

Relative Dose Intensity and Pathologic Response Rates in Patients With Breast Cancer and With and Without HIV Who Received Neoadjuvant Chemotherapy

PURPOSEPatients who are HIV-positive and have breast cancer have worse overall survival (OS) compared with patients who are HIV-negative. Pathologic complete response (pCR) and relative dose intensity (RDI) of chemotherapy are associated with survival. We assessed whether pCR and RDI rates were lowe...

Full description

Bibliographic Details
Main Authors: Yehoda M. Martei, Mohan Narasimhamurthy, Dipho I. Setlhako, Gezahen Ayane, Tlotlo Ralefala, Sebathu Chiyapo, Robert Gross, Lawrence N. Shulman, Surbhi Grover, Angela DeMichele
Format: Article
Language:English
Published: American Society of Clinical Oncology 2022-05-01
Series:JCO Global Oncology
Online Access:https://ascopubs.org/doi/10.1200/GO.22.00016

Internet

https://ascopubs.org/doi/10.1200/GO.22.00016

Similar Items